Abstract:
The Gothenburg based nanobiotechnology company Nanoxis AB recently secured a 1.75 MSEK financing deal. The investors are Creandum KB, The Technology Link Foundation in Gothenburg (TBSG), The Holding Company at the University of Göteborg (GU Holding AB) and AB Chalmersinvest. The company is currently developing nanoanalytical platforms (proteinchips) for identification of certain proteins important for drug development and biotech industry.